Participated · Series B · Oct 2025

Founded in 2015 by Jogin Desai, Rajani Battu, and Rajarshi Pal, Eyestem is focused on cell replacement therapies for retinal disorders. Its lead candidate, Eyecyte-RPE, aims to treat dry age-related macular degeneration by using retinal pigment epithelium cells derived from human stem cells to restore damaged retinal tissue. The company remains in the pre-revenue stage and generated Rs 2.92 crore in non-operating income during FY24 while reporting a net loss of Rs 12.18 crore. Post-money, Eyestem’s valuation has risen roughly 70% to Rs 592 crore (about $67 million). To date, the firm has raised roughly $20 million, including a $6.4 million Series A in August 2022. Major external shareholders now include Jacesa Investments (12.5%), Cytespace (9.64%), and Endiya Partners (7.12%), while the co-founders collectively hold 21.19%. The fresh capital is expected to advance clinical development and expand the company’s pipeline of regenerative eye treatments.

Led · Seed · Sep 2024

Exakt Health provides an AI-driven digital sports physiotherapy app that delivers personalised and dynamically adapting running training and injury-prevention programs. Its product is the first digital sports physiotherapy certified as a medical device in Germany. The company has partnered with German private insurer Barmenia to make the app available free to 300,000 of Barmenia’s customers and is pursuing collaborations with other insurers. CEO Philip Billaudelle says the app digitises professional coaching to adapt to users’ fitness, injuries, and progress, addressing limitations of static pre-packaged plans. Exakt Health plans to launch intelligent AI-based running training plans in the coming weeks and to conduct extensive clinical studies to provide ongoing medical validation. Management aims to grow its user base from 200,000 to over one million within 18 months and will use the new funding to expand the product and clinical validation. Exakt Health is a Berlin-based health tech startup that offers a free app providing digital physiotherapy for sports injuries. The platform delivers customised treatment plans and daily exercises across a range of conditions, including Achilles tendonitis, plantar fasciitis and meniscus tears, and supports four languages. Founded in 2021 by ex-N26 employees Philipp Billaudelle and Lucia Payo, the app has over 8,000 users in the EU and the U.K. With the new funding, the company plans to roll out additional training plans for ankle sprains, gluteal muscle strains and patellar tendinitis. Exakt intends to seek FDA approval and use the capital to expand its app into the U.S. market. The company received a $1.5 million pre-seed funding round to support these product rollouts and international expansion.

Led · Seed · Oct 2023

Healthcaters is a healthtech startup that enables companies to monitor and improve employees’ health. The company offers a dual-component product: a medical self-screening station and an AI-powered health coaching app. The screening station tests 27 health indicators with the support of a virtual health assistant; results are immediately analyzed in the app to produce a 360° health assessment and evidence-based action points. The app aims to help employees minimize doctor visits and sick days by teaching proactive health management. Healthcaters raised $1.2M in Seed funding to support product development and team expansion, with plans to make assessments more accessible in Germany and expand to other international markets. The company serves corporate clients including Barmenia, Cargill and WeWork.

Participated · Seed · Jul 2023

eaze is a Berlin-based health tech start-up that offers a personalised sleep coaching app. The app delivers cognitive behavioural therapy (CBT)-based, data-driven treatment online by qualified sleep experts and provides hyper-personalised access to a sleep psychologist via an intelligent chat app. The company positions its solution as a long-term, scalable treatment for sleep problems rather than a short-term fix, describing the product as "highly-scalable." Founders are CEO Tim Seifferth, COO Timur Nohut and CPO Noah Nawara. To date the company reports over 1,000 paying customers. It has raised a €1.7 million pre-seed round to support growth and scaling.